Royalty Pharma (NasdaqGS:RPRX) FY Conference September 09, 2025 03:20 PM ET Company ParticipantsTerry Coyne - CFOPablo Legorreta - CEOConference Call ParticipantsTerrence Flynn - AnalystTerrence FlynnGreat. Thanks for joining us everybody. I'm Terrence Flynn, Morgan Stanley's U.S. Biopharma analyst. Very pleased to be hosting Royalty Pharma this afternoon. Joining us from the company, we have Pablo Legorreta, who is the company's Founder and CEO, and Terry Coyne, the company's CFO. Thank you both so much fo ...